| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ... Journal of hepatology 73 (1), 202-209, 2020 | 3965 | 2020 |
| Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis T Karlas, D Petroff, M Sasso, JG Fan, YQ Mi, V de Lédinghen, M Kumar, ... Journal of hepatology 66 (5), 1022-1030, 2017 | 1115 | 2017 |
| Epidemiology of Helicobacter pylori Infection and Public Health Implications KL Goh, WK Chan, S Shiota, Y Yamaoka Helicobacter 16, 1-9, 2011 | 811 | 2011 |
| The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease M Eslam, SK Sarin, VWS Wong, JG Fan, T Kawaguchi, SH Ahn, ... Hepatology international 14, 889-919, 2020 | 735 | 2020 |
| FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation … PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ... The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020 | 692 | 2020 |
| Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—part 1: definition, risk factors and assessment VWS Wong, WK Chan, S Chitturi, Y Chawla, YY Dan, A Duseja, J Fan, ... Journal of gastroenterology and hepatology 33 (1), 70-85, 2018 | 535 | 2018 |
| Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal, M Trauner, J Boursier, ... Gut 71 (5), 1006-1019, 2022 | 435 | 2022 |
| Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials SA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ... Journal of hepatology 73 (1), 26-39, 2020 | 418 | 2020 |
| Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review WK Chan, KH Chuah, RB Rajaram, LL Lim, J Ratnasingam, ... Journal of obesity & metabolic syndrome 32 (3), 197, 2023 | 283 | 2023 |
| A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis CW Kheong, NRN Mustapha, S Mahadeva Clinical Gastroenterology and Hepatology 15 (12), 1940-1949. e8, 2017 | 267 | 2017 |
| Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease WK Chan, NR Nik Mustapha, S Mahadeva Journal of gastroenterology and hepatology 29 (7), 1470-1476, 2014 | 227 | 2014 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 224 | 2022 |
| The Asia–Pacific Working Party on non‐alcoholic fatty liver disease guidelines 2017—part 2: management and special groups S Chitturi, VWS Wong, WK Chan, GLH Wong, SKH Wong, J Sollano, ... Journal of gastroenterology and hepatology 33 (1), 86-98, 2018 | 216 | 2018 |
| Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis D Petroff, V Blank, PN Newsome, CS Voican, M Thiele, V de Lédinghen, ... The Lancet Gastroenterology & Hepatology 6 (3), 185-198, 2021 | 212 | 2021 |
| Appointment waiting times and education level influence the quality of bowel preparation in adult patients undergoing colonoscopy WK Chan, A Saravanan, J Manikam, KL Goh, S Mahadeva BMC gastroenterology 11, 1-9, 2011 | 183 | 2011 |
| Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus LL Lai, SR Vethakkan, NR Nik Mustapha, S Mahadeva, WK Chan Digestive diseases and sciences 65, 623-631, 2020 | 182 | 2020 |
| Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease VWS Wong, M Irles, GLH Wong, S Shili, AWH Chan, W Merrouche, ... Gut 68 (11), 2057-2064, 2019 | 164 | 2019 |
| Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement GLH Wong, VWS Wong, A Thompson, J Jia, J Hou, CRA Lesmana, ... The Lancet Gastroenterology & Hepatology 5 (8), 776-787, 2020 | 158 | 2020 |
| Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores AJ Sanyal, J Foucquier, ZM Younossi, SA Harrison, PN Newsome, ... Journal of hepatology 78 (2), 247-259, 2023 | 138 | 2023 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 128 | 2023 |
Sanjiv MahadevaDepartment of Medicine, Faculty of Medicine, University of MalayaEmail được xác minh tại ummc.edu.my
